FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

This adverse event was reported 31 times

These drugs are most commonly taken by patients reporting FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS:

# Drug Count
0 CYCLOSPORINE 10
1 METHOTREXATE SODIUM 10
2 METHOTREXATE 9
3 ALEMTUZUMAB 6
4 CYCLOPHOSPHAMIDE 6
5 CYCLOPHOSPHAMIDE FOR INJECTION 6
6 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 6
7 ETOPOSIDE 5
8 PREDNISONE 5
9 RUXOLITINIB 5
See all common drugs associated with FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EMAPALUMAB-LZSG 1 0.0042
1 MEFENAMIC ACID 3 0.0014
2 CEMIPLIMAB-RWLC 1 0.0005
3 ALEMTUZUMAB 6 0.0003
4 DEXMEDETOMIDINE 1 0.0003
5 DIMENHYDRINATE 3 0.0003
6 CEFOTAXIME INJECTION 1 0.0002
7 ANAKINRA 3 0.0002
8 CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE 3 0.0001
9 ANTI-THYMOCYTE GLOBULIN (RABBIT) 1 0.0001
See all drugs enriched for association with FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS